IRIS International, a manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories, has entered into a strategic partnership with Digital Images Diagnostic (China) for its Urinalysis product line in China.
As per the deal, Digital Images will have rights in China for the sale, marketing and service of IRIS’ iQ(R)200 Sprint, Elite and Select series of Automated Urine Microscopy Analyzers, the iChem Velocity Automated Urine Chemistry Analyzer, and the combined iRICELL workstation.
Thomas Warekois, vice president and president of diagnostics business unit at Iris, said: “We are delighted to establish a strategic partnership with Digital Images Diagnostic in China. Digital Images Diagnostic’s strong focus on imaging-based diagnostic products combined with its nationwide sales network, provides IRIS a solid platform for further penetrating the Chinese market with our automated urinalysis systems.
“With more than 1,400 Level Three tertiary hospitals and strong public funding support from the Chinese government, the China market represents a significant growth opportunity. We look forward to developing a long and mutually beneficial relationship with Digital Images Diagnostic.”
Clement Pun, general manager at Digital Images Diagnostic, said: “This transaction will give Digital Images Diagnostic a set of new product offerings in the urinalysis area. As more Chinese hospitals and clinical labs look to cutting-edge medical technologies to deliver greater efficiencies and better diagnostic information, we are delighted to be the strategic partner with IRIS building on the strong reputation of this notable product line.”
Sales for IRIS’s complete line of automated urinalysis products will commence immediately with the currently registered products of iQ200 Sprint, Elite and Select analyzers. The company anticipates the registration process for iChem Velocity and iRicell workstation to be completed in 2010.